Skip to main content

Part of the book series: Immunology and Medicine ((IMME,volume 12))

  • 42 Accesses

Abstract

In 1978 the WHO Committee on the Immunology of Leprosy, IMMLEP, defined the development of a prophylactic vaccine against leprosy as an objective of high priority. Ten years later, trials are under way of the approaches they identified, namely, vaccines based on antigenically similar cultivatable mycobacteria, killed Mycobacterium leprae, or of a mixture of killed M. leprae with BCG. This chapter will discuss the rationale for such vaccines, together with the possibility of a second-generation vaccine, based on protective antigens produced either by molecular biology or as synthetic peptides.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Walsh, G. P., Meyers, W. M., Binford, C. H., Gerone, P. J., Wolf, R. H. and Leininger, J. R. (1981). Leprosy — a zoonosis. Lepr. Rev. 52 (Suppl. 1), 77–83

    PubMed  Google Scholar 

  2. Gormus, B. J., Wolf, R. H., Baskin, G. B., Ohkawa, S., Gerone, P. J., Walsh, G. P., Meyers, W. M., Binford, C. H. and Greer, W. E. (1988). A second sooty mangabey monkey with naturally acquired leprosy: first reported possible monkey-to-monkey transmission. Int. J. Lepr., 56, 61–5

    CAS  Google Scholar 

  3. Bloom, B. R. (1983). Rationales for vaccines against leprosy. Int. J. Lepr., 51, 505–9

    CAS  Google Scholar 

  4. Ridley, D. S. and Jopling, W. H. (1966). Classification of leprosy according to immunity; a five group system. Int. J. Lepr., 34, 255–73

    CAS  Google Scholar 

  5. Nathan, C. F., Kaplan, G., Levis, W. R, Nusrat, A, Witmer, M. D., Sherwin, S. A., Job, C. K., Horowitz, C. R., Steinman, R. M. and Cohn, Z. A. (1986). Local and systemic effects of intradermal recombinant interferon gamma in patients with lepromatous leprosy. N. Engl. J. Med., 315, 6–15

    Article  PubMed  CAS  Google Scholar 

  6. Douvas, G. S., Looker, D. L., Vatter, A. E. and Crowle, A. J. (1985). Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect. Immun., 50, 1–8

    PubMed  CAS  Google Scholar 

  7. Godai, T. and Negassi, K. (1973). Subclinical infection in leprosy. Br. Med. J., 2, 557–9

    Article  Google Scholar 

  8. Doull, J. A., Guinto, R. S. and Mabalay, M. C. (1957). Effect of BCG vaccination, lepromin testing and natural causes in inducing reactivity to lepromin and to tuberculin. Int. J. Lepr., 25, 13–37

    PubMed  CAS  Google Scholar 

  9. Shepard, C. C. (1965). Vaccination against experimental infection with Mycobacterium leprae. Am. J. Epidemiol., 81, 150–63

    PubMed  CAS  Google Scholar 

  10. Shepard, C. C. (1976). Vaccination of mice against M. leprae infection. Int. J. Lepr., 44, 222–6

    CAS  Google Scholar 

  11. Fine, P. E. M. (1988). BCG vaccination against tuberculosis and leprosy. Br. Med. Bull., 44, 691–703

    PubMed  CAS  Google Scholar 

  12. Lwin, K., Sundaresan, T., Gyi, M. M., Bechelli, L. M., Tamondong, C., Gallego Garbajosa, P., Sansarricq, H. and Noordeen, S. K. (1985). BCG vaccination of children against leprosy: fourteen-year findings of the trial in Burma. Bull. WHO, 63, 1069–78

    PubMed  CAS  Google Scholar 

  13. Stanley, S. J., Howland, C., Stone, M. M. and Sutherland, I. (1981). BCG vaccination of children against leprosy in Uganda: final results. J. Hyg. (Camb)., 87, 233–48

    Article  CAS  Google Scholar 

  14. Ponnighaus, J. M. and Fine, P. E. M. (1986). The Karonga prevention trial — which BCG? Lepr. Rev., 57 (Suppl. 2), 285–92

    PubMed  Google Scholar 

  15. Shepard, C. C. (1960). The experimental disease that follows the injection of human leprosy bacilli into footpads of mice. J. Exp. Med., 112, 445–54

    Article  PubMed  CAS  Google Scholar 

  16. Kirchheimer, W. F. and Storrs, E. E. (1971). Attempts to establish the armadillo (Dasypus novemcinctus Linn.) as a model for the study of leprosy. 1. Report of lepromatoid leprosy in the experimentally infected armadillo. Int. J. Lepr., 39, 693–702

    CAS  Google Scholar 

  17. Smelt, A. H. M., Rees, R. J. W. and Liew, F. Y. (1981). Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals. Clin. Exp. Immunol., 44, 501–6

    PubMed  CAS  Google Scholar 

  18. Bechelli, L. M., Haddad, N., Pagnano, P. M. G., Neves, R. G., Melchior, E. and Fregnan, R. C. (1980). Double blind trials to determine the late reactivity of leprosy patients and unaffected persons to different concentrations of armadillo lepromin in comparison to human lepromin. Int. J. Lepr., 48, 126–34

    CAS  Google Scholar 

  19. Shepard, C. C., Draper, P, Rees, R J. W. and Lowe, C. (1980). Effect of purification steps on the immunogenicity of Mycobacterium leprae. Br. J. Exp. Pathol., 61, 376–9

    PubMed  CAS  Google Scholar 

  20. Draper, P. (1980). WHO report of the fifth meeting on the immunology of leprosy. Annex 4, WR-MMLEFSWG, (5)80,3, 24-6

    Google Scholar 

  21. Gill, H. K., Mustafa, A. S. and Godai, T. (1986). Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae. Bull. WHO, 64, 121–6

    CAS  Google Scholar 

  22. Gill, H. K., Mustafa, A. S. and Godai, T. (1987). In vitro proliferation of lymphocytes from human volunteers vaccinated with armadillo-derived, killed M. leprae. Int. J. Lepr., 55, 30–5

    CAS  Google Scholar 

  23. Gill, H. K., Mustafa, A. S, Ivanyi, J, Harboe, M. and Godai, T. (1986). Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo-derived M. leprae. Lepr. Rev., 57 (Suppl. 2), 293–300

    PubMed  Google Scholar 

  24. Mustafa, A. S., Gill, H. K., Nerland, A, Britton, W. J., Mehra, V., Bloom, B. R., Young, R. A. and Godal, T. (1986). Human T-cell clones recognise a major M. leprae protein antigen expressed in E. coli. Nature (Lond.), 319, 63–6

    Article  CAS  Google Scholar 

  25. Convit, J., Pinardi, M. E., Rodriguez, Ochoa, G., Ulrich, M., Avila, J. L. and Goikmon-Yakr, M. (1974). Elimination of Mycobacterium leprae subsequent to local in vitro activation of macrophages in lepromatous leprosy by other mycobacteria. Clin. Exp. Immunol., 17, 821–6

    Google Scholar 

  26. Convit, J., Ulrich, M., Aranzazu, N., Castellanos, P. L., Pinardi, M. E. and Reyes, O. (1986). The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Lepr. Rev., 57 (Suppl. 2), 263–73

    PubMed  Google Scholar 

  27. Convit, J., Aranzazu, N., Ulrich, M., Pinardi, M. E., Reyes, O. and Alvarado, J. (1982). Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts. Int. J. Lepr., 50, 415–25

    CAS  Google Scholar 

  28. Rada, E. M., Convit, J., Ulrich, M., Gallinotto, M. E. and Aranzazu, N. (1987). Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG. Int. J. Lepr., 55, 646–50

    CAS  Google Scholar 

  29. Fine, P. E. M., Ponnighaus, J. M., Maine, N., Clarkson, J A. and Bliss, L. (1986). The protective efficiency of BCG against leprosy in Northern Malawi. Lancet, 2, 499–502

    Article  PubMed  CAS  Google Scholar 

  30. Gangal, S. G. and Khanolkar, S. R. (1974). Delayed hypersensitivity in vitro to an acid fast mycobacterium cultivated from human lepromatous leprosy. Indian J. Med. Res., 62, 290–6

    PubMed  CAS  Google Scholar 

  31. Girdhar, B. K. and Desikan, K. V. (1978). Results of skin tests with five different mycobacteria. Lepr. India, 50, 555–9

    PubMed  CAS  Google Scholar 

  32. Deo, M. G., Bapat, C. V., Chullawalla, R. G. and Bhatki, W. S. (1981). Potential anti-leprosy vaccine from killed ICRC bacilli — a clinicopathological study. Indian J. Med. Res., 74, 164–77

    PubMed  CAS  Google Scholar 

  33. Deo, M. G., Bapat, C. V., Bhalerao, V., Chaturvedi, R. M., Bhatki, W. S. and Chullawalla, R. G. (1983). Anti-leprosy potentials of ICRC vaccine: a study in patients and healthy volunteers. Int. J. Lepr., 51, 540–9

    CAS  Google Scholar 

  34. Bhatki, W. S. Chulawala, R. G., Bapat, C. V. and Deo, M. G. (1983). Reversal reactions in lepromatous patients induced by a vaccine containing killed ICRC bacilli — a report of five cases. Int. J. Med., 51, 466–72

    CAS  Google Scholar 

  35. Chaturvedi, R. M., Chirmule, N. B., Yellapurkar, M. V., Shaikh, S. U. and Deo, M. G. (1987). Effects of ICRC anti leprosy vaccine in healthy subjects. Int. J. Lepr., 55, 657–66

    CAS  Google Scholar 

  36. Chirmule, N. B., Chaturvedi, R. M. and Deo, M. G. (1988). Immunogenic ‘subunit’ of the ICRC antileprosy vaccine. Int. J. Lepr., 56, 27–35

    CAS  Google Scholar 

  37. Mustafa, A. S. and Talwar, G. P. (1978). Five cultivatable mycobacterial strains giving blast transformation and leukocyte migration inhibition of leukocytes analogous to Mycobacterium leprae. Lepr. India, 50, 498–508

    PubMed  CAS  Google Scholar 

  38. Chaudhuri, S., Fotedar, A. and Talwar, G. P. (1983). Lepromin conversion in repeatedly lepromin negative BL/LL patients after immunization with autoclaved Mycobacterium w. Int. J. Lepr., 51, 159–68

    CAS  Google Scholar 

  39. Zaheer, S. A., Talwar, G. P., Walia, R. and Mukherjee, R. (1988). Results of one year of phase H/phase III trials with the candidate antileprosy vaccine Mycobacterium w. Health Cooperation Papers, 9, 245

    Google Scholar 

  40. Hunter, S. W. and Brennan, P. J. (1981). A novel phenolic glycolipid from M. leprae possibly involved in immunogenicity and pathogenicity. J. Bacteriol., 147, 728–35

    PubMed  CAS  Google Scholar 

  41. Young, D. B. and Buchanan, T. M. (1983). A serological test for leprosy with a glycolipid specific for M. leprae. Science, 221, 1057–9

    Article  PubMed  CAS  Google Scholar 

  42. Brett, S. J., Lowe, C., Payne, S. N. and Draper, P. (1984). Phenolic glycolipid-1 of Mycobacterium leprae causes non-specific inflammation but has no effect on cell-mediated responses in mice. Infect. Immun., 46, 802–8

    PubMed  CAS  Google Scholar 

  43. Job, C. K., Sanchez, R. M., McCormick, G. T. and Hastings, R. C. (1987). Ability of the phenolic glycolipid-1 antigen of M. leprae to elicit a positive Mitsuda response in the armadillo (Dasypus novemcinctus). Int. J. Lepr., 55, 299–304

    CAS  Google Scholar 

  44. Mehra, V., Brennan, P. J., Rada, E., Convit, J. and Bloom, B. R. (1984). Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature, 308, 194–96

    Article  PubMed  CAS  Google Scholar 

  45. Neill, M. A. and Klebanoff, S. J. (1988). The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages. J. Exp. Med., 167, 30–42

    Article  PubMed  CAS  Google Scholar 

  46. Young, R. A., Mehra, V., Sweetser, D., Buchanan, T., Clark-Curtiss, J., Davis, R. W. and Bloom, B. R. (1985). Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature, 316, 450–2

    Article  PubMed  CAS  Google Scholar 

  47. Britton, W. J., Garsia, R. J., Hellqvist, L., Watson, J. D. and Basten, A. (1986). The characterization and immunoreactivity of a 70 kd protein common to Mycobacterium leprae and Mycobacterium bovis (BCG). Lepro. Rev., 57 (Suppl. 2), 67–75

    Google Scholar 

  48. Young, R. A., Bloom, B. R., Grosskinsky, C. M., Ivanyi, J., Thomas, D. and Davis, R. W. (1985). Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc. Natl. Acad. Sci. USA, 82, 2583–7

    Article  PubMed  CAS  Google Scholar 

  49. Cohen, M. L., Mayer, L. W., Rumschlag, H. S., Yakrus, M. A., Jones, W. D. and Good, R. C. (1987). Expression of proteins of Mycobacterium tuberculosis in Escherichia coli and potential of recombinant genes and proteins for development of diagnostic reagents. J. Clin. Microbiol., 25, 1176–80

    PubMed  CAS  Google Scholar 

  50. Young, D. B., Kent, L. and Young, R. A (1987). Screening of a recombinant mycobacterial DNA library with polyclonal antisera and molecular weight analysis of expressed antigens. Infect. Immun., 55, 1421–5

    PubMed  CAS  Google Scholar 

  51. Thole, J. E. R., Dauwerse, H. G., Das, P. K., Groothuis, D. G., Schouls, L. M. and van Embden, J. D. A. (1985). Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect. Immun., 50, 800–6

    PubMed  CAS  Google Scholar 

  52. Lamb, J. R. and Rees, A. D. M. (1988). Antigen specificity and function of human T lymphocyte clones reactive with mycobacteria. Br. Med. Bull., 44, 600–10

    PubMed  CAS  Google Scholar 

  53. Lamb, J. R. and Young, D. B. (1987). A novel approach to the identification of T-cell epitopes in Mycobacterium tuberculosis using T-lymphocyte clones. Immunology, 60, 1–5

    PubMed  CAS  Google Scholar 

  54. Abou-Zeid, C., Filley, E., Steele, J. and Rook, G. A. W. (1987). A simple new method for using antigens separated by Polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J. Immunol. Meth., 98, 5–10

    Article  CAS  Google Scholar 

  55. Shinnick, T. M., Sweetser, D., Thole, J, van Embden, J. and Young, R. A. (1987). The etiologic agents of leprosy and tuberculosis share an immunoreactive protein antigen with the vaccine strain Mycobacterium bovis BCG. Infect. Immun., 55, 1932–5

    PubMed  CAS  Google Scholar 

  56. Buchanan, T. M., Nomaguchi, H., Anderson, D. C., Young, R. A., Gillis, T. P., Britton, W. J., Ivanyi, J., Kolk, A. H. J., Closs, O., Bloom, R. and Mehra, V. (1986). Characterisation of mycobacterial species specificity of 14 separate epitopes which reacted with monoclonal antibodies to the 65,000 molecular weight protein molecule of Mycobacterium leprae., Lepr. Rev., 57 (Suppl. 2), 63–6

    PubMed  Google Scholar 

  57. Husson, R. N. and Young, R. A. (1987). Genes for the major protein antigens of Mycobacterium tuberculosis: the etiological agents of tuberculosis and leprosy share an immunodominant antigen. Proc. Natl. Acad. Sci. USA, 84, 1679–83

    Article  PubMed  CAS  Google Scholar 

  58. Mehra, V., Sweetser, D., Young, R. A. (1986). Efficient mapping of protein antigenic determinants. Proc. Natl. Acad. Sci. USA, 83, 7013–17

    Article  PubMed  CAS  Google Scholar 

  59. Lamb, J. R., Ivanyi, J., Rees, A. D. M., Rothbard, J. B., Howland, K., Young, R. A. and Young, D. B. (1987). Mapping of T cell epitopes using recombinant antigens and synthetic peptides. EMBO J., 6, 1245–9

    PubMed  CAS  Google Scholar 

  60. Lamb, F. I., Kingston, A. E., Estrada- G. I. and Colston, M. J. (1988). Heterologous expression of the 65-kilodalton antigen of Mycobacterium leprae and murine T-cell responses to the gene product. Infect. Immun., 56, 1237–41

    PubMed  CAS  Google Scholar 

  61. Kaufmann, S. H. E., Vath, U., Thole, J. E. R., van Embden, J. D. A. and Emmrich, F. (1987). Enumeration of T-cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur. J. Immunol., 17, 351–7

    Article  PubMed  CAS  Google Scholar 

  62. Oftung, F., Mustafa, A. S., Husson, R., Young, R. A. and Godai, T. (1987). Human T-cell clones recognise two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli. J. Immunol., 138, 927–31

    PubMed  CAS  Google Scholar 

  63. Emmrich, F., Thole, J., van Embden, J. and Kaufmann, S. H. E. (1986). A recombinant 64 kilodalton protein of Mycobacterium bovis Bacillus Calmette-Guerin specifically stimulates human T4 clones reactive to mycobacterial antigens. J. Exp. Med., 163, 1024–9

    Article  PubMed  CAS  Google Scholar 

  64. Van Schooten, W. C. A., Ottenhoff, T. H. M., Klatser, P. R., Thole, J., de Vries, R. R. P. and Kolk, A. H. J. (1988). T cell epitopes on the 36k and 65k Mycobacterium leprae antigens defined by human T cell clones. Eur. J. Immunol., 18, 849–54

    Article  PubMed  Google Scholar 

  65. Gillis, T. P., Miller, R. A, Young, D. B, Khanolkar, S. R. and Buchanan, T. M. (1985). Immunochemical characterization of a protein associated with Mycobacterium leprae cell wall. Infect. Immun., 49, 371–7

    PubMed  CAS  Google Scholar 

  66. De Bruyn, J., Bosmans, R., Turner, M., Weckx, M., Nyabenda, J., van Vooren, J.-P., Falmagne, P., Wiker, H. G. and Harboe, M. (1987). Purification, partial characterization, and identification of a skin-reactive protein antigen of Mycobacterium bovis BCG. Infect. Immunol., 55, 245–52

    Google Scholar 

  67. Young, D. B., Ivanyi, J., Cox, J. H. and Lamb, J. R. (1987). The 65kDa antigen of mycobacteria — a common bacterial protein? Immunol. Today, 8, 215–19

    Article  CAS  Google Scholar 

  68. Young, D., Lathigra, R., Hendrix, R., Sweetser, D. and Young, R.A. (1988). Stress proteins are immune targets in leprosy and tuberculosis. Proc. Natl. Acad. Sci. USA, 85, 4267–70

    Article  PubMed  CAS  Google Scholar 

  69. Booth, R. J., Harris, D. P., Love, J. M. and Watson, J. D. (1988). Antigenic proteins of Mycobacterium leprae. Complete sequence of the gene for the 18kDa protein. J. Immunol., 140, 597–601

    PubMed  CAS  Google Scholar 

  70. Engers, H. D., Bloom, B. R. and Godai, T. (1985). Monoclonal antibodies against mycobacterial antigens. Immunol. Today, 6, 346–8

    Article  Google Scholar 

  71. Hopwood, D. A., Kieser, T., Colston, M. J. and Lamb, F. I. (1988). Molecular biology of mycobacteria. Br. Med. Bull., 44, 528–46

    PubMed  CAS  Google Scholar 

  72. Bloom, B. R. (1986). Learning from leprosy: a perspective on immunology and the third world. J. Immunol., 137, i–x

    PubMed  CAS  Google Scholar 

  73. Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R. and Jacobs, W. R. (1988). Lysogeny and transformation in mycobacteria. Stable expression of foreign genes. Proc. Natl. Acad. Sci. USA, 85, 6987–91

    Article  PubMed  CAS  Google Scholar 

  74. Zainuddin, Z. F., Kunza, Z. M. and Dale, J. W. (1989). Transformation of Mycobacterium smegmatis with E. coli plasmids carrying a selectable resistance marker. Molec. Microbiol., 3, 29–34

    Article  CAS  Google Scholar 

  75. Klatser, P. R., van Rens, M. M. and Eggelte, T. A. (1984). Immunochemical characterisation of Mycobacterium leprae antigens by the SDS-polyacrylamide gel electrophoresis immuno-peroxidase technique (SGIP) using patients’ sera. Clin. Exp. Immunol., 56, 537–44

    PubMed  CAS  Google Scholar 

  76. Vega-Lopez, F., Stoker, N. G., Locniskar, M. F., Dockrell, H. M., Grant, K. A. and McAdam, K. P. W. J. (1988). Recognition of mycobacterial antigens by sera from patients with leprosy. J. Clin. Microbiol, 26, 2474–9

    PubMed  CAS  Google Scholar 

  77. Rook, G. A. W. (1980). The immunogenicity of killed mycobacteria. Lepr. Rev., 51, 295–301

    PubMed  CAS  Google Scholar 

  78. Rook, G. A. W., Steele, J., Barnass, S., Mace, J. and Stanford, J. L. (1986). Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors. Clin. Exp. Immunol., 63, 105–10

    PubMed  CAS  Google Scholar 

  79. Abou-Zeid, C., Smith, I., Grange, J., Steele, J. and Rook, G. (1986). Subdivision of daughter strains of Bacille Calmette-Guerin (BCG) according to secreted protein patterns. J. Gen. Microbiol., 132, 3047–53

    PubMed  CAS  Google Scholar 

  80. Collins, F. M., Lamb, J. R. and Young, D. B. (1988). Biological activity of protein antigens isolated from Mycobacterium tuberculosis culture filtrate. Infect. Immun., 56, 1260–6,

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Dockrell, H.M., McAdam, K.P.W.J. (1989). Immunization against leprosy. In: Zuckerman, A.J. (eds) Recent Developments in Prophylactic Immunization. Immunology and Medicine, vol 12. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1067-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1067-6_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6969-4

  • Online ISBN: 978-94-009-1067-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics